EGFR and neoplasm: Our group has characterized the genomic landscape of a broad range of pituitary adenomas including functional and non-functional tumors, and there do not appear to be recurrent alterations in some of the genes, such as PTEN and EGFR, that have been implicated in PD-L1 upregulation in other tumor types.